Maryland Vision Institute Frederick

Elizabeth O. Segal, M.D., is a board-certified ophthalmologist with over 20 years of experience in Frederick, Maryland. Dr. Segal treats the full range of ophthalmic illness. Call for an appointment if you are having trouble with cataracts, glaucoma, floaters and flashers, simple refractive error (i.e. basic trouble seeing), or any other problem with your eyes. Making an appointment if you are in good ophthalmic health but haven't seen an ophthalmologist in more than a year. Also visit our website today!

Located in Frederick MD Robert B Hodges MD practices at the Frederick Eye Institute. As an M.D. specializing in General and Allopathic Medicine Dr. Hodges brings a wealth of medical knowledge and expertise to his practice. With a focus on providing comprehensive medical care Dr. Hodges offers patients top-notch medical services. Patients can trust in Dr. Hodges' commitment to delivering high-quality healthcare and his dedication to promoting overall well-being. Generated from this place's public information

Bryce Chiang, M.D., Ph.D., is an assistant professor of ophthalmology and a glaucoma specialist at the Wilmer Eye Institute, Johns Hopkins Medicine East Baltimore location. His clinical interests include the medical and surgical management of glaucoma and cataract. After receiving his combined bachelor’s/master’s degrees in biomedical engineering from The Johns Hopkins University, Dr. Chiang completed joint M.D./Ph.D. degrees at the Emory University School of Medicine. During his doctorate in biomedical engineering at the Georgia Institute of Technology, Dr. Chiang became interested in ophthalmology through his research in ocular drug delivery. He served as a medicine intern at Highland Hospital in Oakland, California, and completed his ophthalmology residency, glaucoma fellowship and innovation fellowship at the Byers Eye Institute at Stanford University. Dr. Chiang’s research interests include targeted ocular drug delivery, specifically within the suprachoroidal space and to the optic nerve head. He studied the pharmacokinetics of microneedle injections into the suprachoroidal space while pursuing his doctorate at Georgia Tech, and maintains an interest in the suprachoroidal space as a means of altering disease trajectory. Furthermore, despite the optic nerve head being the site of disease in optic neuropathies, no therapies exist that treat the optic nerve head. By directly treating the diseased tissue, targeting therapeutics to the optic nerve head may enable paradigm shifting therapies for optic neuropathies. Targeted delivery to the optic nerve head may also serve as a research tool to query the pathogenesis of glaucoma.